Sign inGet started

ATAI

AtaiBeckley Inc.CIK 2081043 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26

AI insights for ATAI PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for ATAI
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Barrett Christopher Ryan CaveSee remarks25$0$02026-09-11
Hoffman John FrancisDirector6$0$02026-09-11
Craig Kevin JamesChief Medical Officer37$0$775.5K2026-09-11
Short Glenn FrankChief Scientific Officer26$0$17.8K2026-09-11
Kochendoerfer GerdChief Operating Officer12$0$250.0K2026-09-11
Johnson Anne NagengastChief Financial Officer32$0$96.0K2026-09-11
Rao SrinivasSee remarks, Director46$52.5K$215.8K2026-09-11
Angermayer ChristianDirector, 10% Owner42$14.19M$02026-09-11
Smiley Andrea HeslinDirector19$70.0K$02026-09-11
Faerm Michael E.Chief Financial Officer6$0$02026-09-11
Braunstein ScottDirector13$0$02026-09-11
Kalali Amir HDirector19$70.0K$02026-09-11
Fischer LaurentDirector9$0$02026-09-11
HERSHBERG ROBERTDirector20$0$496.0K2026-09-11
JOHNSON SABRINA MARTUCCIDirector16$0$02026-09-11
Apeiron Investment Group Ltd.10% Owner18$46.14M$02026-04-08
Feilding-Mellen CosmoDirector6$0$154.4K2026-01-02
Kirpekar SahilChief Business Officer10$0$131.8K2025-03-21
Brand FlorianSee Remarks16$219.8K$290.5K2024-10-04
Auerbach MichaelDirector6$70.0K$02024-06-13
Camm JasonDirector2$0$02023-05-23
Bardin StephenChief Financial Officer2$0$02023-03-14
Gutierrez-Esteinou RolandoChief Medical Officer6$0$02023-03-14
de Rosnay AlexisDirector3$70.0K$02022-05-25
WEAVER GREGORY LChief Financial Officer3$70.0K$02022-03-02
Presight II, LP10% Owner1$10.50M$02021-06-22

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-11624,000— $00SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-1164,000— $00SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-1117,930— $00SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-111,247,932— $00SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-11131,698— $00SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-11103,000— $00SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-11121,968— $00SEC↗
JOHNSON SABRINA MARTUCCIDirector D To issuer deriv2026-09-112026-09-11103,000— $00SEC↗
JOHNSON SABRINA MARTUCCIDirector D To issuer deriv2026-09-112026-09-11103,000— $00SEC↗
JOHNSON SABRINA MARTUCCIDirector D To issuer deriv2026-09-112026-09-1164,000— $00SEC↗
JOHNSON SABRINA MARTUCCIDirector D To issuer deriv2026-09-112026-09-1164,000— $00SEC↗
JOHNSON SABRINA MARTUCCIDirector D To issuer deriv2026-09-112026-09-11121,968— $00SEC↗
HERSHBERG ROBERTDirector D To issuer deriv2026-09-112026-09-11404,869— $00SEC↗
HERSHBERG ROBERTDirector D To issuer deriv2026-09-112026-09-1148,858— $00SEC↗
HERSHBERG ROBERTDirector D To issuer deriv2026-09-112026-09-11121,968— $00SEC↗
HERSHBERG ROBERTDirector D To issuer deriv2026-09-112026-09-11103,000— $00SEC↗
HERSHBERG ROBERTDirector D To issuer deriv2026-09-112026-09-1162,394— $00SEC↗
Braunstein ScottDirector D To issuer deriv2026-09-112026-09-1156,818— $00SEC↗
Braunstein ScottDirector D To issuer deriv2026-09-112026-09-11208,063— $00SEC↗
Braunstein ScottDirector D To issuer deriv2026-09-112026-09-11103,000— $00SEC↗
Braunstein ScottDirector D To issuer deriv2026-09-112026-09-11206,000— $00SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2026-09-112026-09-1164,000— $00SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2026-09-112026-09-11103,000— $00SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2026-09-112026-09-11103,000— $00SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2026-09-112026-09-1164,000— $00SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2026-09-112026-09-11121,968— $00SEC↗
Kalali Amir HDirector D To issuer deriv2026-09-112026-09-11103,000— $00SEC↗
Kalali Amir HDirector D To issuer deriv2026-09-112026-09-11103,000— $00SEC↗
Kalali Amir HDirector D To issuer deriv2026-09-112026-09-11121,968— $00SEC↗
Kalali Amir HDirector D To issuer deriv2026-09-112026-09-1164,000— $00SEC↗
Kalali Amir HDirector D To issuer deriv2026-09-112026-09-1164,000— $00SEC↗
Hoffman John FrancisDirector D To issuer deriv2026-09-112026-09-11206,000— $00SEC↗
Hoffman John FrancisDirector D To issuer deriv2026-09-112026-09-11121,968— $00SEC↗
Fischer LaurentDirector D To issuer deriv2026-09-112026-09-11121,968— $00SEC↗
Fischer LaurentDirector D To issuer deriv2026-09-112026-09-11206,000— $00SEC↗
Fischer LaurentDirector D To issuer deriv2026-09-112026-09-11103,000— $00SEC↗
Faerm Michael E.Chief Financial Officer D To issuer deriv2026-09-112026-09-11285,000— $00SEC↗
Faerm Michael E.Chief Financial Officer D To issuer deriv2026-09-112026-09-111,275,000— $00SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11283,280— $00SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11329,552— $00SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11757,915— $00SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-1171,620— $00SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11250,000— $00SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11388,000— $00SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11675,000— $00SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11180,000— $00SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11150,000— $00SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11550,000— $00SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11757,915— $00SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11175,000— $00SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11150,000— $00SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11675,000— $00SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11347,000— $00SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11284,832— $00SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11231,900— $00SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-1171,620— $00SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11400,000— $00SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11500,000— $00SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11550,000— $00SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-1171,620— $00SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11200,000— $00SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11326,416— $00SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11117,000— $00SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11525,000— $00SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11757,915— $00SEC↗
Rao SrinivasSee remarks D To issuer deriv2026-09-112026-09-111,988,000— $00SEC↗
Rao SrinivasSee remarks D To issuer deriv2026-09-112026-09-11777,400— $00SEC↗
Rao SrinivasSee remarks D To issuer deriv2026-09-112026-09-11800,000— $00SEC↗
Rao SrinivasSee remarks D To issuer deriv2026-09-112026-09-112,340,000— $00SEC↗
Rao SrinivasSee remarks D To issuer deriv2026-09-112026-09-11600,000— $00SEC↗
Rao SrinivasSee remarks D To issuer deriv2026-09-112026-09-11442,000— $00SEC↗
Rao SrinivasSee remarks D To issuer deriv2026-09-112026-09-11650,795— $00SEC↗
Rao SrinivasSee remarks D To issuer deriv2026-09-112026-09-11217,778— $00SEC↗
Rao SrinivasSee remarks D To issuer deriv2026-09-112026-09-112,147,408— $00SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-11372,701— $00SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-1128,608— $00SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-1150,400— $00SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-1110,000— $00SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-11150,000— $00SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-11675,000— $00SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-11673,808— $00SEC↗
Kochendoerfer GerdChief Operating Officer D To issuer deriv2026-09-112026-09-111,400,000— $00SEC↗
Kochendoerfer GerdChief Operating Officer D To issuer deriv2026-09-112026-09-11675,000— $00SEC↗
Kochendoerfer GerdChief Operating Officer D To issuer deriv2026-09-112026-09-11150,000— $00SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer2026-09-112026-09-111,799,302— $00SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer2026-09-112026-09-11559,232— $00SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer2026-09-112026-09-1153,398,214— $00SEC↗
Smiley Andrea HeslinDirector D To issuer2026-09-112026-09-114,666— $00SEC↗
Kalali Amir HDirector D To issuer2026-09-112026-09-114,666— $00SEC↗
Short Glenn FrankChief Scientific Officer D To issuer2026-09-112026-09-1142,333— $00SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer2026-09-112026-09-11155,066— $00SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer2026-09-112026-09-11140,045— $00SEC↗
Rao SrinivasSee remarks D To issuer2026-09-112026-09-11212,942— $00SEC↗
Rao SrinivasSee remarks D To issuer2026-09-112026-09-113,500— $00SEC↗
Craig Kevin JamesChief Medical Officer D To issuer2026-09-112026-09-118,437— $00SEC↗
Kochendoerfer GerdChief Operating Officer D To issuer deriv2026-09-112026-09-11150,000— —0SEC↗
Kochendoerfer GerdChief Operating Officer D To issuer deriv2026-09-112026-09-11675,000— —0SEC↗
Kochendoerfer GerdChief Operating Officer D To issuer deriv2026-09-112026-09-111,400,000— —0SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-11150,000— —0SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-11675,000— —0SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-11673,808— —0SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-11372,701— —0SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-1128,608— —0SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-1150,400— —0SEC↗
Craig Kevin JamesChief Medical Officer D To issuer deriv2026-09-112026-09-1110,000— —0SEC↗
Craig Kevin JamesChief Medical Officer D To issuer2026-09-112026-09-118,437— —0SEC↗
Rao SrinivasSee remarks, Director D To issuer deriv2026-09-112026-09-11442,000— —0SEC↗
Rao SrinivasSee remarks, Director D To issuer deriv2026-09-112026-09-111,988,000— —0SEC↗
Rao SrinivasSee remarks, Director D To issuer deriv2026-09-112026-09-112,340,000— —0SEC↗
Rao SrinivasSee remarks, Director D To issuer deriv2026-09-112026-09-11800,000— —0SEC↗
Rao SrinivasSee remarks, Director D To issuer deriv2026-09-112026-09-11600,000— —0SEC↗
Rao SrinivasSee remarks, Director D To issuer deriv2026-09-112026-09-11777,400— —0SEC↗
Rao SrinivasSee remarks, Director D To issuer deriv2026-09-112026-09-112,147,408— —0SEC↗
Rao SrinivasSee remarks, Director D To issuer deriv2026-09-112026-09-11217,778— —0SEC↗
Rao SrinivasSee remarks, Director D To issuer deriv2026-09-112026-09-11650,795— —0SEC↗
Rao SrinivasSee remarks, Director D To issuer2026-09-112026-09-113,500— —0SEC↗
Rao SrinivasSee remarks, Director D To issuer2026-09-112026-09-11212,942— —0SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11117,000— —0SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11525,000— —0SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11757,915— —0SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11550,000— —0SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11500,000— —0SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-1171,620— —0SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11200,000— —0SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer deriv2026-09-112026-09-11326,416— —0SEC↗
Johnson Anne NagengastChief Accounting Officer D To issuer2026-09-112026-09-11140,045— —0SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11150,000— —0SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11675,000— —0SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11175,000— —0SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11757,915— —0SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11550,000— —0SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11400,000— —0SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-1171,620— —0SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11231,900— —0SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11284,832— —0SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer deriv2026-09-112026-09-11347,000— —0SEC↗
Barrett Christopher Ryan CaveSee remarks D To issuer2026-09-112026-09-11155,066— —0SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11150,000— —0SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11675,000— —0SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11757,915— —0SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11388,000— —0SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11250,000— —0SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-1171,620— —0SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11180,000— —0SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11329,552— —0SEC↗
Short Glenn FrankChief Scientific Officer D To issuer deriv2026-09-112026-09-11283,280— —0SEC↗
Short Glenn FrankChief Scientific Officer D To issuer2026-09-112026-09-1142,333— —0SEC↗
Faerm Michael E.Chief Financial Officer D To issuer deriv2026-09-112026-09-11285,000— —0SEC↗
Faerm Michael E.Chief Financial Officer D To issuer deriv2026-09-112026-09-111,275,000— —0SEC↗
Fischer LaurentDirector D To issuer deriv2026-09-112026-09-11121,968— —0SEC↗
Fischer LaurentDirector D To issuer deriv2026-09-112026-09-11103,000— —0SEC↗
Fischer LaurentDirector D To issuer deriv2026-09-112026-09-11206,000— —0SEC↗
Hoffman John FrancisDirector D To issuer deriv2026-09-112026-09-11121,968— —0SEC↗
Hoffman John FrancisDirector D To issuer deriv2026-09-112026-09-11206,000— —0SEC↗
Kalali Amir HDirector D To issuer deriv2026-09-112026-09-11121,968— —0SEC↗
Kalali Amir HDirector D To issuer deriv2026-09-112026-09-11103,000— —0SEC↗
Kalali Amir HDirector D To issuer deriv2026-09-112026-09-11103,000— —0SEC↗
Kalali Amir HDirector D To issuer deriv2026-09-112026-09-1164,000— —0SEC↗
Kalali Amir HDirector D To issuer deriv2026-09-112026-09-1164,000— —0SEC↗
Kalali Amir HDirector D To issuer2026-09-112026-09-114,666— —0SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2026-09-112026-09-11121,968— —0SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2026-09-112026-09-11103,000— —0SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2026-09-112026-09-11103,000— —0SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2026-09-112026-09-1164,000— —0SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2026-09-112026-09-1164,000— —0SEC↗
Smiley Andrea HeslinDirector D To issuer2026-09-112026-09-114,666— —0SEC↗
Braunstein ScottDirector D To issuer deriv2026-09-112026-09-11208,063— —0SEC↗
Braunstein ScottDirector D To issuer deriv2026-09-112026-09-1156,818— —0SEC↗
Braunstein ScottDirector D To issuer deriv2026-09-112026-09-11103,000— —0SEC↗
Braunstein ScottDirector D To issuer deriv2026-09-112026-09-11206,000— —0SEC↗
HERSHBERG ROBERTDirector D To issuer deriv2026-09-112026-09-11121,968— —0SEC↗
HERSHBERG ROBERTDirector D To issuer deriv2026-09-112026-09-11103,000— —0SEC↗
HERSHBERG ROBERTDirector D To issuer deriv2026-09-112026-09-1162,394— —0SEC↗
HERSHBERG ROBERTDirector D To issuer deriv2026-09-112026-09-11404,869— —0SEC↗
HERSHBERG ROBERTDirector D To issuer deriv2026-09-112026-09-1148,858— —0SEC↗
JOHNSON SABRINA MARTUCCIDirector D To issuer deriv2026-09-112026-09-11121,968— —0SEC↗
JOHNSON SABRINA MARTUCCIDirector D To issuer deriv2026-09-112026-09-11103,000— —0SEC↗
JOHNSON SABRINA MARTUCCIDirector D To issuer deriv2026-09-112026-09-11103,000— —0SEC↗
JOHNSON SABRINA MARTUCCIDirector D To issuer deriv2026-09-112026-09-1164,000— —0SEC↗
JOHNSON SABRINA MARTUCCIDirector D To issuer deriv2026-09-112026-09-1164,000— —0SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-11121,968— —0SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-11103,000— —0SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-11131,698— —0SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-111,247,932— —0SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-1117,930— —0SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-1164,000— —0SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer deriv2026-09-112026-09-11624,000— —0SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer2026-09-112026-09-111,799,302— —0SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer2026-09-112026-09-1153,398,214— —0SEC↗
Angermayer ChristianDirector, 10% Owner D To issuer2026-09-112026-09-11559,232— —0SEC↗
HERSHBERG ROBERTDirector M Exercise deriv2026-07-072026-07-0948,858— $048,858SEC↗
HERSHBERG ROBERTDirector M Exercise deriv2026-07-072026-07-0951,142— $0404,869SEC↗
HERSHBERG ROBERTDirector M Exercise2026-07-072026-07-0948,858$1.35 $66.0K48,858SEC↗
HERSHBERG ROBERTDirector M Exercise2026-07-072026-07-0951,142$1.35 $69.0K100,000SEC↗
HERSHBERG ROBERTDirector S Sale2026-07-072026-07-09100,000$4.96 $496.0K100,000SEC↗
Kochendoerfer GerdChief Operating Officer M Exercise deriv2026-06-262026-06-2950,000— $01,400,000SEC↗
Kochendoerfer GerdChief Operating Officer S Sale2026-06-262026-06-2950,000$5.00 $250.0K0SEC↗
Kochendoerfer GerdChief Operating Officer M Exercise2026-06-262026-06-2950,000$1.60 $80.0K50,000SEC↗
Craig Kevin JamesChief Medical Officer M Exercise deriv2026-06-252026-06-2933,051— $0673,808SEC↗
Craig Kevin JamesChief Medical Officer M Exercise deriv2026-06-252026-06-299,528— $028,608SEC↗
Craig Kevin JamesChief Medical Officer M Exercise2026-06-252026-06-2933,051$1.50 $49.6K41,488SEC↗
Craig Kevin JamesChief Medical Officer M Exercise2026-06-252026-06-299,528$1.18 $11.2K51,016SEC↗
Craig Kevin JamesChief Medical Officer S Sale2026-06-252026-06-2942,579$4.51 $192.0K8,437SEC↗
JOHNSON SABRINA MARTUCCIDirector A Award deriv2026-06-042026-06-08121,968— $0121,968SEC↗
Smiley Andrea HeslinDirector A Award deriv2026-06-042026-06-08121,968— $0121,968SEC↗
Kalali Amir HDirector A Award deriv2026-06-042026-06-08121,968— $0121,968SEC↗
Hoffman John FrancisDirector A Award deriv2026-06-042026-06-08121,968— $0121,968SEC↗
HERSHBERG ROBERTDirector A Award deriv2026-06-042026-06-08121,968— $0121,968SEC↗
Fischer LaurentDirector A Award deriv2026-06-042026-06-08121,968— $0121,968SEC↗
Braunstein ScottDirector A Award deriv2026-06-042026-06-08121,968— $0121,968SEC↗
Braunstein ScottDirector A Award deriv2026-06-042026-06-0886,095— $086,095SEC↗
Angermayer ChristianDirector, 10% Owner A Award deriv2026-06-042026-06-08121,968— $0121,968SEC↗
Craig Kevin JamesChief Medical Officer M Exercise deriv2026-04-202026-04-2227,280— $0706,859SEC↗
Craig Kevin JamesChief Medical Officer M Exercise deriv2026-04-202026-04-2215,299— $0372,701SEC↗
Craig Kevin JamesChief Medical Officer S Sale2026-04-202026-04-2242,579$5.00 $212.9K8,437SEC↗
Craig Kevin JamesChief Medical Officer M Exercise2026-04-202026-04-2215,299$1.84 $28.2K51,016SEC↗
Craig Kevin JamesChief Medical Officer M Exercise2026-04-202026-04-2227,280$1.50 $40.9K35,717SEC↗
Apeiron Investment Group Ltd.10% Owner M Exercise deriv2026-04-082026-04-1046,070— $017,930SEC↗
Apeiron Investment Group Ltd.10% Owner M Exercise deriv2026-04-082026-04-10103,000— $00SEC↗
Apeiron Investment Group Ltd.10% Owner M Exercise deriv2026-04-082026-04-10410,162— $0231,838SEC↗
Apeiron Investment Group Ltd.10% Owner M Exercise2026-04-082026-04-1046,070$1.88 $86.6K46,070SEC↗
Apeiron Investment Group Ltd.10% Owner M Exercise2026-04-082026-04-10410,162$1.64 $672.7K456,232SEC↗
Apeiron Investment Group Ltd.10% Owner M Exercise2026-04-082026-04-10103,000$1.34 $138.0K559,232SEC↗
Craig Kevin JamesChief Medical Officer M Exercise deriv2026-03-202026-03-2476,224— $038,136SEC↗
Craig Kevin JamesChief Medical Officer M Exercise deriv2026-03-202026-03-2423,776— $0734,139SEC↗
Craig Kevin JamesChief Medical Officer M Exercise2026-03-202026-03-2423,776$1.50 $35.7K108,437SEC↗
Craig Kevin JamesChief Medical Officer M Exercise2026-03-202026-03-2476,224$1.18 $89.9K84,661SEC↗
Craig Kevin JamesChief Medical Officer S Sale2026-03-202026-03-24100,000$3.55 $355.0K8,437SEC↗
Faerm Michael E.Chief Financial Officer A Award deriv2026-03-112026-03-13285,000— $0285,000SEC↗
Faerm Michael E.Chief Financial Officer A Award deriv2026-03-112026-03-131,275,000— $01,275,000SEC↗
Craig Kevin JamesChief Medical Officer A Award deriv2026-01-302026-02-03675,000— $0675,000SEC↗
Craig Kevin JamesChief Medical Officer A Award deriv2026-01-302026-02-03150,000— $0150,000SEC↗
Short Glenn FrankChief Scientific Officer A Award deriv2026-01-302026-02-03675,000— $0675,000SEC↗
Short Glenn FrankChief Scientific Officer A Award deriv2026-01-302026-02-03150,000— $0150,000SEC↗
Rao SrinivasSee remarks A Award deriv2026-01-302026-02-03442,000— $0442,000SEC↗
Rao SrinivasSee remarks A Award deriv2026-01-302026-02-031,988,000— $01,988,000SEC↗
Kochendoerfer GerdChief Operating Officer A Award deriv2026-01-302026-02-03675,000— $0675,000SEC↗
Kochendoerfer GerdChief Operating Officer A Award deriv2026-01-302026-02-03150,000— $0150,000SEC↗
Johnson Anne NagengastChief Financial Officer A Award deriv2026-01-302026-02-03117,000— $0117,000SEC↗
Johnson Anne NagengastChief Financial Officer A Award deriv2026-01-302026-02-03525,000— $0525,000SEC↗
Barrett Christopher Ryan CaveSee remarks A Award deriv2026-01-302026-02-03150,000— $0150,000SEC↗
Barrett Christopher Ryan CaveSee remarks A Award deriv2026-01-302026-02-03675,000— $0675,000SEC↗
Feilding-Mellen CosmoDirector S Sale2026-01-022026-01-0639,594$3.90 $154.4K7,663,396SEC↗
Feilding-Mellen CosmoDirector A Award deriv2025-11-252025-11-2610,000— $010,000SEC↗
Feilding-Mellen CosmoDirector D To issuer deriv2025-11-252025-11-2640,400— $00SEC↗
Feilding-Mellen CosmoDirector A Award deriv2025-11-052025-11-06103,000— $0103,000SEC↗
Feilding-Mellen CosmoDirector A Award deriv2025-11-052025-11-0640,400— $040,400SEC↗
HERSHBERG ROBERTDirector A Award deriv2025-11-052025-11-06103,000— $0103,000SEC↗
HERSHBERG ROBERTDirector A Award deriv2025-11-052025-11-0662,394— $062,394SEC↗
HERSHBERG ROBERTDirector A Award deriv2025-11-052025-11-0697,716— $097,716SEC↗
HERSHBERG ROBERTDirector A Award deriv2025-11-052025-11-06456,011— $0456,011SEC↗
Feilding-Mellen CosmoDirector A Award2025-11-052025-11-067,702,990— $07,702,990SEC↗
Braunstein ScottDirector A Award deriv2025-11-042025-11-0656,818— $056,818SEC↗
Barrett Christopher Ryan CaveSee Remarks A Award deriv2025-10-012025-10-03175,000— $0175,000SEC↗
Apeiron Investment Group Ltd.10% Owner C Conversion deriv2025-09-302025-10-02147,950— $00SEC↗
Apeiron Investment Group Ltd.10% Owner C Conversion2025-09-302025-10-022,367,200— $053,412,414SEC↗
Apeiron Investment Group Ltd.10% Owner P Buy2025-08-142025-08-188,675,799$2.19 $19.00M51,045,214SEC↗
Rao SrinivasSee Remarks A Award deriv2025-08-132025-08-15650,794— $0650,794SEC↗
Rao SrinivasSee Remarks A Award deriv2025-08-132025-08-15217,777— $0217,777SEC↗
Angermayer ChristianDirector, 10% Owner A Award deriv2025-06-262025-06-27103,000— $0103,000SEC↗
Braunstein ScottDirector A Award deriv2025-06-262025-06-27103,000— $0103,000SEC↗
Fischer LaurentDirector A Award deriv2025-06-262025-06-27103,000— $0103,000SEC↗
Hoffman John FrancisDirector A Award deriv2025-06-262025-06-27206,000— $0206,000SEC↗
JOHNSON SABRINA MARTUCCIDirector A Award deriv2025-06-262025-06-27103,000— $0103,000SEC↗
Kalali Amir HDirector A Award deriv2025-06-262025-06-27103,000— $0103,000SEC↗
Smiley Andrea HeslinDirector A Award deriv2025-06-262025-06-27103,000— $0103,000SEC↗
Angermayer ChristianDirector, 10% Owner A Award deriv2025-06-022025-06-04131,698— $0131,698SEC↗
Apeiron Investment Group Ltd.10% Owner P Buy2025-03-242025-03-241,800,000$1.40 $2.52M42,369,415SEC↗
Short Glenn FrankChief Scientific Officer S Sale2025-03-212025-03-2413,161$1.35 $17.8K42,333SEC↗
Johnson Anne NagengastChief Financial Officer S Sale2025-03-212025-03-2433,545$1.35 $45.3K140,045SEC↗
Rao SrinivasSee Remarks S Sale2025-03-212025-03-2475,418$1.35 $101.8K212,942SEC↗
Craig Kevin JamesChief Medical Officer S Sale2025-03-212025-03-2411,563$1.35 $15.6K8,437SEC↗
Kirpekar SahilChief Business Officer S Sale2025-03-212025-03-2448,563$1.35 $65.6K115,636SEC↗
Johnson Anne NagengastChief Financial Officer M Exercise deriv2025-03-142025-03-19100,000— $00SEC↗
Kirpekar SahilChief Business Officer M Exercise deriv2025-03-142025-03-19100,000— $00SEC↗
Rao SrinivasSee Remarks M Exercise deriv2025-03-142025-03-19175,000— $00SEC↗
Short Glenn FrankChief Scientific Officer M Exercise deriv2025-03-142025-03-1932,500— $00SEC↗
Craig Kevin JamesChief Medical Officer M Exercise deriv2025-03-142025-03-1920,000— $00SEC↗
Johnson Anne NagengastChief Financial Officer M Exercise2025-03-142025-03-19100,000— $0173,590SEC↗
Kirpekar SahilChief Business Officer M Exercise2025-03-142025-03-19100,000— $0164,199SEC↗
Rao SrinivasSee Remarks M Exercise2025-03-142025-03-19175,000— $0288,360SEC↗
Short Glenn FrankChief Scientific Officer M Exercise2025-03-142025-03-1932,500— $055,494SEC↗
Craig Kevin JamesChief Medical Officer M Exercise2025-03-142025-03-1920,000— $020,000SEC↗
Johnson Anne NagengastChief Financial Officer A Award deriv2025-03-032025-03-05757,915— $0757,915SEC↗
Craig Kevin JamesChief Medical Officer A Award deriv2025-03-032025-03-06757,915— $0757,915SEC↗
Short Glenn FrankChief Scientific Officer A Award deriv2025-03-032025-03-06757,915— $0757,915SEC↗
Apeiron Investment Group Ltd.10% Owner P Buy2025-02-142025-02-1910,835,718$2.10 $22.76M40,555,215SEC↗
Rao SrinivasSee Remarks A Award deriv2025-01-072025-01-102,340,000— $02,340,000SEC↗
Kochendoerfer GerdChief Operating Officer A Award deriv2025-01-022025-01-031,450,000— $01,450,000SEC↗
Brand FlorianSee Remarks A Award deriv2024-10-042024-10-044,240,000— $04,240,000SEC↗
Brand FlorianSee Remarks A Award deriv2024-10-042024-10-04400,688— $0400,688SEC↗
Brand FlorianSee Remarks A Award deriv2024-10-042024-10-04338,112— $0338,112SEC↗
Brand FlorianSee Remarks D To issuer deriv2024-10-042024-10-044,240,000— $00SEC↗
Brand FlorianSee Remarks D To issuer deriv2024-10-042024-10-04338,112— $00SEC↗
Brand FlorianSee Remarks D To issuer deriv2024-10-042024-10-04400,688— $00SEC↗
Rao SrinivasSee Remarks D To issuer deriv2024-10-042024-10-04709,952— $00SEC↗
Rao SrinivasSee Remarks D To issuer deriv2024-10-042024-10-04840,000— $00SEC↗
Rao SrinivasSee Remarks A Award deriv2024-10-042024-10-04840,000— $0840,000SEC↗
Rao SrinivasSee Remarks A Award deriv2024-10-042024-10-04709,952— $0709,952SEC↗
Rao SrinivasSee Remarks D To issuer deriv2024-10-042024-10-041,307,408— $00SEC↗